P-cadherin Activators

Common P-cadherin Activators include, but are not limited to Retinoic Acid, all trans CAS 302-79-4, 5-Aza-2′-Deoxycytidine CAS 2353-33-5, β-Estradiol CAS 50-28-2, Rapamycin CAS 53123-88-9 and Progesterone CAS 57-83-0.

P-cadherin activators refer to substances or compounds that influence the activity or expression of P-cadherin, a cell adhesion molecule belonging to the cadherin superfamily. P-cadherin, short for placental cadherin, is a calcium-dependent transmembrane protein that plays a pivotal role in cell-cell adhesion and tissue organization. It is especially prevalent in tissues where strong adhesion between cells is crucial, such as the epidermis, hair follicles, and the placenta. P-cadherin is integral for maintaining tissue integrity, and its dysregulation has been associated with various pathological conditions, including cancer.

The activation of P-cadherin involves a complex interplay of intracellular signaling pathways and calcium ions. P-cadherin activators can modulate these processes, either by promoting P-cadherin-mediated cell adhesion or by influencing downstream signaling events. These activators can serve as valuable tools for researchers studying cell adhesion, tissue development, and cancer biology. By understanding how P-cadherin functions and how it can be influenced, scientists can gain insights into the mechanisms underlying tissue formation, maintenance, and disease progression. Moreover, P-cadherin activators may have applications in tissue engineering, where controlling cell adhesion is critical for creating functional and stable tissues in regenerative medicine.